6.4.2. controversies definitions clinically relevant psa relapse. psa level defines treatment failure depends primary treatment. patients rising psa rp primary rt different risks subsequent symptomatic metastatic disease based various parameters, including psa level. therefore, physicians carefully interpret bcr endpoints comparing treatments. clinicians interpret psa rise light eau bcr risk groups (see section 6.3.3). rp, threshold best predicts metastases psa > 0.4 ng/ml rising [894-896]. however, access ultra-sensitive psa testing, rising psa much level cause concern patients. primary rt, without short-term hormonal manipulation, rtog-astro phoenix consensus conference definition psa failure (with accuracy > 80% clinical failure) ‘any psa increase > 2 ng/ml higher psa nadir value, regardless serum concentration nadir’ . hifu cryotherapy endpoints validated clinical progression survival; therefore, possible give firm recommendation acceptable psa threshold alternative local treatments .